Related Experiment Video
Updated: Apr 24, 2026

08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
33.3K
Autonomic system and amyotrophic lateral sclerosis
Ezequiel A Piccione1, David M Sletten, Nathan P Staff
1Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, USA, 55905.
Muscle & Nerve
|September 12, 2014
Summary
Autonomic nervous system impairment is common in motor neuron disease, primarily mild and affecting cardiovagal and sudomotor functions. Upper motor neuron presentations show greater autonomic dysfunction.
Area of Science:
- Neurology
- Autonomic Neuroscience
Background:
- Motor neuron disease (MND) encompasses a group of progressive neurodegenerative disorders.
- Autonomic dysfunction is increasingly recognized as a component of MND.
Purpose of the Study:
- To characterize the prevalence and patterns of autonomic impairment in patients with motor neuron disease.
- To investigate differences in autonomic dysfunction across subtypes of MND.
Main Methods:
- Retrospective analysis of neurological evaluations and autonomic function tests in 132 patients.
- Classified patients into classic amyotrophic lateral sclerosis (ALS), lower motor neuron (LMN), and upper motor neuron (UMN) predominant disease.
- Utilized the Composite Autonomic Severity Score (CASS) to quantify autonomic impairment.
Main Results:
- 75% of patients exhibited autonomic impairment, with mild (CASS 1-3) in 85% and moderate (CASS 4-7) in 15%.
- Sudomotor (46%) and cardiovagal (50%) functions were most frequently affected.
- UMN-predominant disease showed significantly higher CASS scores compared to classic ALS and LMN groups.
Conclusions:
- Motor neuron disease patients frequently experience mild autonomic impairment, predominantly affecting cardiovagal and sudomotor systems.
- Moderate autonomic failure occurs in approximately 14% of patients, particularly those with UMN involvement.
- Autonomic pathway impairment may be more pronounced in patients with selective corticospinal tract involvement.
Related Concept Videos
Cross-bridge Cycle
108.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
108.5K
Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
Chemical Synapses
10.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.8K
Autonomic Nervous System: Overview
6.3K
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
6.3K
Autonomic Nervous System
31.4K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
31.4K
Myasthenia Gravis ll: Pathophysiology
34
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
34

